AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Structure Therapeutics Inc. Director's Dealing 2024

Jun 27, 2024

31940_dirs_2024-06-27_51c317f4-3bc8-487c-b778-3a9e26adcd7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-06-25

Reporting Person: Waldstreicher Joanne (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-25	Share Option (right to buy)	$13.32	A	37500	Acquired	2034-06-24	Ordinary Shares (37500)	Direct

Footnotes

F1: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2: The shares vest in equal monthly installments over the 12 months following June 25, 2024.

F3: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.